Blue Fin Capital, Inc. Abbott Laboratories Transaction History
Blue Fin Capital, Inc.
- $494 Million
- Q2 2024
A detailed history of Blue Fin Capital, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 17,492 shares of ABT stock, worth $1.99 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
17,492
Previous 17,607
0.65%
Holding current value
$1.99 Million
Previous $2 Million
9.2%
% of portfolio
0.37%
Previous 0.45%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,136Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$19 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.48 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.19 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.53 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...